You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2024

Litigation Details for Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)

✉ Email this page to a colleague

« Back to Dashboard

Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)

Docket	⤷ Sign Up	Date Filed	2015-11-04
Court	District Court, D. Delaware	Date Terminated	2019-09-05
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Patents	8,017,150; 8,475,832; 8,603,514
Link to Docket	External link to docket

Small Molecule Drugs cited in Indivior Inc. v. Mylan Technologies Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Indivior Inc. v. Mylan Technologies Inc. (D. Del. 2015)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2015-11-04	1	Complaint	United States Patent Nos. 8,475,832 (“the ʼ832 patent”), 8,017,150 (“the ʼ150 patent”), and 8,603,514…ʼ150 patent, and Plaintiff Indivior is an exclusive licensee of the ʼ150 patent. The ʼ150 patent, entitled…ʼ514 patent, and Plaintiff Indivior is an exclusive licensee of the ʼ514 patent. The ʼ514 patent, entitled…is an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United…8,603,514 (“the ’514 patent”) (collectively, “the patents-in-suit”). Case 1:15-cv-01016-RGA Document 1 Filed	External link to document
2017-05-30	147	Notice of Service	Regarding Alvogen's Infringement of U.S. Patent Number 8,017,150; and 5. Expert Report of Dr. Robert K. …'homme Regarding Alvogen's Infringement of U.S. Patent Number 8,603,514; 3. Expert Report of Martyn C.… Ph.D. Regarding Alvogen's Infringement of U.S. Patent No. 8,603,514; 4. Expert Report of Dr. Robert K…'homme Regarding Alvogen's Infringement of U.S. Patent Number 8,900,497. filed by Indivior Inc., Indivior…November 2015 8 May 2018 1:15-cv-01016 830 Patent None District Court, D. Delaware	External link to document
2017-05-30	149	Notice of Service	. Regarding Mylan's Infringement of U.S. Patent No. 8,603,514; 3. Expert Report of Dr. Robert K. Prud'…Regarding Mylan's Infringement of U.S. Patent Number 8,603,514; and 4. Expert Report of Dr. Robert K. …Prud'homme Regarding Mylan's Infringement of U.S. Patent Number 8,900,497 filed by Indivior Inc., Indivior…November 2015 8 May 2018 1:15-cv-01016 830 Patent None District Court, D. Delaware	External link to document
2017-06-29	155	Notice of Service	Fassihi, Ph.D. Regarding Infringement of U.S. Patent Nos. 8,017,150 and 8,900,497 HIGHLY CONFIDENTIAL - OUTSIDE…Marcio S. Carvalho Regarding Infringement of U.S. Patent Nos. 8,603,514 and 8,900,497; and 2) Rebuttal Expert…November 2015 8 May 2018 1:15-cv-01016 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.